The Rise of ‘Bait-and- Switch Pricing’
Emily Stewart, Business Insider
Vytorin Cholesterol Pill
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since acquired) over its cholesterol medication Vytorin. The settlement is for a whopping $688 million. The two lawsuits were filed by shareholders of the companies and alleged, among other things, that the companies made false and misleading statements regarding the effectiveness and economic success of the drug in press releases and other public disclosures.
The Latest
TINA.org Finds U-Haul Using Bait-and-Switch Pricing Scheme
MADISON, CONN. May 6, 2025 – U-Haul is engaged in a bait-and-switch pricing scheme with its $19.95 truck rental ads, according to an investigation by consumer advocacy organization truthinadvertising.org (TINA.org).…
U-Haul Needs to Pack Up Its Deceptive ‘$19.95’ Truck Ads
TINA.org calls on regulators to stop moving company’s bait and switch.
FTC, Nevada Sue IM Mastery Academy
Complaint alleges IML was a $1.2 billion scam.
OmegaXL: Backed by Research
What you should know about ingredient studies.